Essais liés11clinical trials
VilleMaitlandlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07843459

Ouvrir le site du centre

Essais cliniques associés

11
MoléculeIndication / populationPhaseNCTTitreStatut
JNJ-63733657 Alzheimer Phase 2 NCT04619420 Autonomy — A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease TERMINATED
[18F]PI-2620 Alzheimer Phase 3 NCT05641688 [18F]PI-2620 Phase 3 Histopathological Study RECRUITING
LY4560736 Alzheimer Phase 1 NCT07843459 A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD) NOT_YET_RECRUITING
LY4405094 Alzheimer Phase 1 NCT07787169 A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease RECRUITING
LY4405094 Alzheimer Phase 1 NCT07787182 A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease RECRUITING
ITI-1284 Alzheimer Phase 2 NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia RECRUITING
ITI-1284 Alzheimer Phase 2 NCT06540833 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease RECRUITING
RAP-219 Épilepsie Phase 3 NCT07594119 FOCUS 2 — Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures RECRUITING
LY3439539 Alzheimer Phase 1 NCT07598370 A Study of LY3439539 in Participants With Alzheimer's Disease RECRUITING
SNK01 Alzheimer Phase 1/2 NCT06189963 Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease RECRUITING
CVN424 75 mg Parkinson Phase 3 NCT06553027 To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications ACTIVE_NOT_RECRUITING